Percutaneous Coronary Intervention Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Precision PCI Registry
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Other: DNA sample collection Sponsors: University of Florida; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI); University of Maryland, Baltimore Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials

REgiStry-based Cardiovascular qUality improvEment Research
Conditions: Percutaneous Coronary Intervention; Heart Failure; Cardiometabolic Syndrome; Structural Heart Abnormality Interventions: Behavioral: Cardiac rehabilitation; Other: Active post-market surveillance of devices; Other: Multi-omics approach to precision medicine; Other: The prescription pattern analysis Sponsors: Peking University Third Hospital; Peking University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials

VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)
Conditions: High-risk Percutaneous Coronary Intervention; Heart Disease, Coronary Interventions: Device: VITALYST System Sponsors: Boston Scientific Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials

Complex CAD Treated With PCI With DES Implantation.
Conditions: Complex Coronary Artery Disease Interventions: Procedure: Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation Sponsors: Poznan University of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials

A Clinical Study for the Pan-vascular Interventional Robotic System
Conditions: Percutaneous Coronary Intervention; Pan-vascular Interventional Robotic System Interventions: Device: Pan-vascular interventional robotic system Sponsors: Shenzhen Aibo Medical Robot Co., LTD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials

Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation; Coronary Artery Disease Interventions: Drug: Rivaroxaban Sponsors: J.P.S Henriques Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

Magenta Elevate ™ First-in-Human Clinical Study in High-Risk PCI Patients
Conditions: High-Risk Percutaneous Coronary Intervention Interventions: Device: The Elevate ™ System Sponsors: Magenta Medical Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials

Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Conditions: Acute Coronary Syndrome; Non ST Segment Elevation Acute Coronary Syndrome Interventions: Drug: Tafolecimab; Drug: Cholesterol Absorption Inhibitor; Drug: Statin Sponsors: China National Center for Cardiovascular Diseases; Innovent Biologics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease Interventions: Drug: Colchicine 0.5 MG Oral Tablet; Drug: Placebo Sponsors: AZ Sint-Jan AV; University Hospital, Ghent; Belgium Health Care Knowledge Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials

Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention
Conditions: Coronary Artery Disease Interventions: Drug: Cangrelor 50 MG Sponsors: Federico II University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

Patient Centered Machine Learning Model for Bleeding and Ischemic Risk
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Device: Percutaneous coronary intervention Sponsors: Abbott Medical Devices; Icahn School of Medicine at Mount Sinai Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

Evaluation of Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Device: Genoss DES stent Sponsors: Genoss Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).
Conditions: Coronary Artery Disease; Drug Coated-balloon; Intravascular Ultrasound; Plaque Modification; Percutaneous Coronary Intervention; Microvascular Coronary Artery Disease Interventions: Device: Drug coated-balloon percutaneous coronary intervention.; Device: Angiography-derived coronary physiology (IMRangio) Sponsors: Hospital Universitario La Fe Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

Different Doses of Colchicine on hsCRP
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Drug: Colchicine 0.5 MG; Drug: Colchicine 0.375 MG; Drug: Colchicine 0.25 MG; Drug: Placebo Sponsors: Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

Patients With Acute Coronary Syndrome (ACS) Treated With GENOSSTM Sirolimus-eluting Stent
Conditions: Acute Coronary Syndrome; Percutaneous Coronary Intervention Interventions: Device: Genoss DES Sponsors: Genoss Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials